Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Hyper N-Glycosylated SEL1L3 As B-Cell Receptor Autoantigen of Primary Vitreoretinal Lymphoma

Moritz Bewarder, Michelle Elbert, Konstantinos Christofyllakis, Kristina Heyne, Gabi Carbon, Natalie Fadle, Evi Regitz, Maximilian Kiefer, Igor Age Kos, Joerg Thomas Bittenbring, Frank Neumann, Falko Fend, Irina Bonzheim, Lorenz Thurner

Blood (2022) 140 (Supplement 1): 3042–3043.

https://doi.org/10.1182/blood-2022-170027

Published: 2022

Journal Articles

Fast-Track Schedule for Vitamin D3 Substitution in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Jonas Matthias Jabs, Viola Poeschel, MD, Martin Sökler, MD, Kerstin Habersang, MD, Rolf Mahlberg, MD, Ulrich Keller, Professor Dr, Heinz-Gert Hoeffkes, Professor Dr, Andreas Rank, PD Dr, Andreas Viardot, Professor Dr, Andreas Neubauer, Professor Dr, Marita Ziepert, PhD, Bettina Altmann, PhD, Stephan Stilgenbauer, MD, Michael Pfreundschuh, Professor Dr, Gerhard Held, Professor Dr, Joerg Thomas Bittenbring, MD

Blood (2020) 136 (Supplement 1): 11.

https://doi.org/10.1182/blood-2020-134944

Published: 2020

Journal Articles

Salvage High-Dose Melphalane and Autologous Peripheral Blood Stem Cell Transplantation for Diffuse Large b-Cell Lymphoma Refractory to 2nd or 3rd Line Treatment

Dominic Kaddu-Mulindwa, Gerhard Held, MD, Michael Pfreundschuh, MD, PhD, Joerg Thomas Bittenbring, MD

Blood (2016) 128 (22): 5881.

https://doi.org/10.1182/blood.V128.22.5881.5881

Published: 2016

Journal Articles

Outcomes of Mismatched Related Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Blood (2016) 128 (22): 3504.

https://doi.org/10.1182/blood.V128.22.3504.3504

Published: 2016

Journal Articles

the IKZF1-IRF4 Axis Regulates Macrophage Polarization and Macrophage-Mediated Anti-Tumor Immunity

Heiko Bruns, PhD, Dimitrios Mougiakakos, Christian Bach, Martin Böttcher, Joerg Thomas Bittenbring, MD, Maike Büttner, Kolja Gelse, Michael Rehli, Julia Wimmer, Fabian Beier, MD, Deniz Gezer, Jan Krönke, MD, Heidi Balzer, Stephanie Moi, Bernd Spriewald, MD, Andreas Mackensen, MD, Leonhard Busch

Blood (2016) 128 (22): 2514.

https://doi.org/10.1182/blood.V128.22.2514.2514

Published: 2016

Journal Articles

Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Ritgen, Donald Bunjes, Matthias Zeis, Michael Stadler, MD, Joerg Thomas Bittenbring, MD, Ute Hegenbart, Michael Hallek, Michael Kneba, Norbert Schmitz, MD, PhD, Hartmut Döhner, MD, Peter Dreger, MD

Blood (2016) 128 (22): 682.

https://doi.org/10.1182/blood.V128.22.682.682

Published: 2016

Journal Articles

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT

Florent Malard, MD PhD, Myriam Labopin, MD, Gernot Stuhler, MD, Johanna Tischer, MD, Joerg Thomas Bittenbring, MD, Arnold Ganser, MD, Nicolaus Kroeger, MD, Donald Bunjes, MD, Christoph Schmid, MD, Jiri Mayer, Prof., MD, Mauricette Michallet, MD PhD, Michael Hallek, MD, Bipin N. Savani, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3105.

https://doi.org/10.1182/blood.V126.23.3105.3105

Published: 2015

Journal Articles

Lenalidomide Enhances MOR202 Dependent Macrophage-Mediated Effector Functions Via the Vitamin D Pathway

Heiko Bruns, PhD, Regina Jitschin, PhDMD, Dimitrios Mougiakakos, Joerg Thomas Bittenbring, MD, Jens Nolting, Maike Büttner, Michael Rehli, PhD, Julia Wimmer, Frank Neumann, PhD, Christian Bach, Heidi Balzer, Stephanie Moi, Peter Brossart, MD, Armin Gerbitz, MD, Andreas Mackensen, MD

Blood (2015) 126 (23): 2203.

https://doi.org/10.1182/blood.V126.23.2203.2203

Published: 2015

Journal Articles

Optimizing 25-OH-Vitamin D3 Serum Levels for Rituximab- and Obinutuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity

Joerg Thomas Bittenbring, MD, Michael Pfreundschuh, MD, Fabian Acker, Frank Neumann, PhD

Blood (2015) 126 (23): 2734.

https://doi.org/10.1182/blood.V126.23.2734.2734

Published: 2015

Journal Articles

Vitamin D-Dependent Induction of Cathelicidin in Human Macrophages Results in Cytotoxicity Against High Grade B-Cell Lymphoma

Heiko Bruns, PhD, Maike Büttner, Mario Fabri, Dimitrios Mougiakakos, Joerg Thomas Bittenbring, MD, Shirin Pasemann, Frank Neumann, Anna Maurberger, Bettina Kempkes, Andreas Mackensen, Armin Gerbitz, MD

Blood (2014) 124 (21): 4108.

https://doi.org/10.1182/blood.V124.21.4108.4108

Published: 2014

Journal Articles

25-OH-Vitamin-D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Is Associated With An Inferior Outcome Of Elderly DLBCL Patients Treated With Rituximab

Joerg Thomas Bittenbring, Bettina Altmann, Frank Neumann, Marina Achenbach, Joerg Reichrath, Marita Ziepert, Juergen Geisel, Evi Regitz, Gerhard Held, Michael Pfreundschuh, MD Prof

Blood (2013) 122 (21): 1819.

https://doi.org/10.1182/blood.V122.21.1819.1819

Published: 2013

Journal Articles

Identification of New Minor Histocompatibility Antigens (mHags) in Patients with Chronic Graft Versus Host Disease (GvH) after Allogeneic Stem Cell Transplantation by SEREX.

Joerg Thomas Bittenbring, Manfred Ahlgrimm, Markus Ditschkowski, Frank Neumann, Joerg Schubert, Klaus-Dieter Preuss, Dietrich Wilhelm Beelen, MD, Michael Pfreundschuh

Blood (2008) 112 (11): 2198.

https://doi.org/10.1182/blood.V112.11.2198.2198

Published: 2008

NARROW

Hyper N-Glycosylated SEL1L3 As B-Cell Receptor Autoantigen of Primary Vitreoretinal Lymphoma

Fast-Track Schedule for Vitamin D3 Substitution in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Salvage High-Dose Melphalane and Autologous Peripheral Blood Stem Cell Transplantation for Diffuse Large b-Cell Lymphoma Refractory to 2nd or 3rd Line Treatment

Outcomes of Mismatched Related Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

the IKZF1-IRF4 Axis Regulates Macrophage Polarization and Macrophage-Mediated Anti-Tumor Immunity

Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT

Lenalidomide Enhances MOR202 Dependent Macrophage-Mediated Effector Functions Via the Vitamin D Pathway

Optimizing 25-OH-Vitamin D3 Serum Levels for Rituximab- and Obinutuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity

Vitamin D-Dependent Induction of Cathelicidin in Human Macrophages Results in Cytotoxicity Against High Grade B-Cell Lymphoma

25-OH-Vitamin-D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Is Associated With An Inferior Outcome Of Elderly DLBCL Patients Treated With Rituximab

Identification of New Minor Histocompatibility Antigens (mHags) in Patients with Chronic Graft Versus Host Disease (GvH) after Allogeneic Stem Cell Transplantation by SEREX.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only